Cytological Examination of Breast Ductal Fluids (Ductal Lavage, Nipple Aspirate Fluid, Fiberoptic Ductoscopy) for Cancer Screening/Diagnosis (Nebraska Only)
State-specific UnitedHealthcare Medical Policy for Nebraska addressing use of ductal lavage, nipple aspirate fluid cytology, and fiberoptic ductoscopy for breast cancer screening, diagnosis, or as alternative tools to guide surgery; describes evidence, FDA context, and coding reference.
Created state-specific policy version for the state of Nebraska.
Updated supporting information sections (Description of Services, Clinical Evidence, FDA, References) to reflect current information.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.